Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 270
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +252 more
Jun 20, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Anniston, Alabama
  • +145 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +230 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, basal insulin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • basal insulin
  • Birmingham, Alabama
  • +57 more
May 28, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +98 more
May 28, 2019

Diabetes, Type 2 Trial in Worldwide (ipragliflozin, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +58 more
May 20, 2019

Diabetes, Type 2 Trial in Canada, United Kingdom, United States (OneTouch® Ultra®2 System, Standard care)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • OneTouch® Ultra®2 System
  • Standard care
  • Phoenix, Arizona
  • +17 more
May 3, 2019

Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (insulin degludec, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec
  • insulin glargine
  • Birmingham, Alabama
  • +165 more
Apr 30, 2019

Diabetes, Type 2 Trial in Worldwide (Placebo, Linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Huntsville, Alabama
  • +648 more
Mar 21, 2019

Diabetes, Type 2 Trial in United States (GLWL-01, Part A, Placebo, Part A, GLWL-01, Part B)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • GLWL-01, Part A
  • +5 more
  • Tempe, Arizona
  • +3 more
Mar 19, 2019

Diabetes, Type 2 Trial in Canada, United States (ITCA 650 20/60 mcg/day, Empagliflozin (oral), Glimepiride (oral))

Terminated
  • Diabetes Mellitus, Type 2
  • ITCA 650 20/60 mcg/day
  • +2 more
  • Fountain Hills, Arizona
  • +100 more
Mar 4, 2019

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, liraglutide, exenatide)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • +2 more
  • Birmingham, Alabama
  • +108 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin glargine
  • Fresno, California
  • +90 more
Dec 7, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/liraglutide, insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • insulin degludec/liraglutide
  • insulin degludec
  • Huntsville, Alabama
  • +85 more
Dec 7, 2018

Diabetes, Type 2, Cardiovascular Diseases, Risk Factors Trial in Worldwide (Placebo, Canagliflozin (JNJ-28431754) 100 mg,

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • +2 more
  • Placebo
  • +2 more
  • Birmingham, Alabama
  • +312 more
Nov 5, 2018

Diabetes, Type 2 Trial in Worldwide (Bolus Insulin Patch (Calibra Finesse), Insulin Pen (Novo-Nordisk FlexPen®))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Bolus Insulin Patch (Calibra Finesse)
  • Insulin Pen (Novo-Nordisk FlexPen®)
  • Phoenix, Arizona
  • +51 more
Nov 6, 2018

Diabetes, Type 2 Trial in United States (ITCA 650 Osmotic Mini Pump 20/60 mcg/day, ITCA 650 Osmotic Mini Pump 60 mcg/day,

Completed
  • Diabetes Mellitus, Type 2
  • ITCA 650 Osmotic Mini Pump 20/60 mcg/day
  • +3 more
  • Birmingham, Alabama
  • +35 more
Nov 1, 2018

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, sitagliptin, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Phoenix, Arizona
  • +105 more
Sep 3, 2018

Diabetes, Type 2 Trial in Puerto Rico, United States (Insulin glargine, Inhaled Insulin (Exubera))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine
  • Inhaled Insulin (Exubera)
  • Phoenix, Arizona
  • +72 more
Aug 31, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin glargine, 300U/mL, Insulin degludec, 100 U/mL, Non-insulin anti-diabetic treatment)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin glargine, 300U/mL
  • +2 more
  • Sheffield, Alabama
  • +157 more
Aug 14, 2018

Diabetes, Diabetes, Type 2 Trial in United States (rosiglitazone, inhaled human insulin, metformin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Hueytown, Alabama
  • +102 more
Sep 3, 2018

Diabetes, Diabetes, Type 2 Trial in United States (pioglitazone, inhaled human insulin)

Terminated
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Ozark, Alabama
  • +109 more
Sep 3, 2018

Diabetes, Type 2 Trial in Worldwide (, linagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Sheffield, Alabama
  • +144 more
Jun 1, 2018

Diabetes, Type 2 Trial in United States (Exenatide once weekly suspension, Exenatide twice daily)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Exenatide once weekly suspension
  • Exenatide twice daily
  • Muscle Shoals, Alabama
  • +57 more
Jun 4, 2018

Diabetes, Type 2 Trial in Germany, Lithuania, United States (LY2409021, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +18 more
Mar 24, 2018